Ariane Backes, Rodrigo Vianna and Thiago Beduschi* Pages 3418 - 3424 ( 7 )
Visceral transplant represents an immunologic challenge due to high intestinal graft immunogenicity. Over the last 20 years, significant advances in immunosuppression regimens have resulted in excellent short-term outcomes.
Currently, visceral transplant is the standard of care for patients with gut failure having life-threatening complications and complex abdominal pathology. In this review, we describe immunosuppressive strategies in the visceral transplant field.
Intestinal transplant, visceral transplant, multi-visceral transplant, immunosuppression, future perspectives, current trends.
UF Health Shands Transplant Center, Division of Transplantation and Hepatobiliary Surgery, University of Florida, Gainesville, Florida, UF Health Shands Transplant Center, Division of Transplantation and Hepatobiliary Surgery, University of Florida, Gainesville, Florida, UF Health Shands Transplant Center, Division of Transplantation and Hepatobiliary Surgery, University of Florida, Gainesville, Florida